Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Girdhar Bk is active.

Publication


Featured researches published by Girdhar Bk.


Microbes and Infection | 2009

Induction of lepromin reactivity in cured lepromatous leprosy patients: impaired chemokine response dissociates protective immunity from delayed type hypersensitivity

Dipendra K. Mitra; Beenu Joshi; Amit K. Dinda; Ambak Kumar Rai; Girdhar Bk; Kiran Katoch; Maninder S. Bindra; Utpal Sengupta

Delayed Type Hypersensitivity (DTH) and protective immunity are thought to be tightly linked. Remarkable similarity exists between their cellular and immune mechanisms. However, their dissociation is also well known. Here we investigate the immunological mechanisms relevant for their dissociation in a group of non-relapsing cured lepromatous leprosy (CLL) patients. In these patients, using lepromin reaction as a model system of DTH we report critical role of tissue chemokine response in synchronous manifestation of these linked phenomena. Results indicate elevation of the threshold of tissue chemokine induction thus dissociating DTH from protective immunity in lepromin -ive CLL patients. We also show that the DTH anergy in these subjects is not an absolute one but depends on the strength of the stimulus. Our data provide insights into the intricate relationship between DTH and immunity and highlight the persistent presence of effector immune mechanisms involving these two pathways in apparently unresponsive lepromatous leprosy patients.


Leprosy Review | 1991

Nasal myiasis in leprosy.

Husain S; Malaviya Gn; Girdhar A; Sreevatsa; Girdhar Bk

Infestation of the nose with larvae of certain files can occur in leprosy patients. This results in severe distress and agony and can cause extensive tissue damage. The predisposing factors, clinical presentation and treatment is described.


Leprosy Review | 1990

Preliminary observations on myiasis in leprosy patients.

Sreevatsa; Malaviya Gn; Husain S; Girdhar A; H. R. Bhat; Girdhar Bk

Out of 3350 leprosy patients attending the surgical outpatient department for various ulcerative lesions, 18 patients had typical symptoms of myiasis. Maggots were collected in 5 cases from the nose, in 3 cases from ulcers of the hand and in 10 cases from ulcers of the foot. It was possible to rear the maggots into flies in 8 out of 18 cases. The flies were identified as Sarcophaga ruficornis and Chrysomyia bezziana.


Leprosy Review | 1997

Excretion of clofazimine in human milk in leprosy patients

Venkatesan K; Mathur A; Girdhar A; Girdhar Bk

Clofazimine is an important and effective constituent of multi drug therapy for leprosy. A study has been conducted to determine the distribution of clofazimine in maternal milk so that the safety of breast-feeding during maternal ingestion of the drug can be ascertained. Eight female leprosy patients (LL/BL) on clofazimine, 50 mg daily or 100 mg on alternate days for 1-18 months, (mean 5.0 +/- 1.81 months; median 3.25 months) and in the early lactating phase were studied. Blood samples and milk specimens were collected 4-6 hr after the last daily dose. Clofazimine was assayed in the milk and plasma samples by HPTLC. Mean plasma and milk clofazimine levels were 0.9 +/- 0.03 micrograms/ml and 1.33 +/- 0.09 micrograms/ml respectively. The ratio of milk to plasma drug concentration ranged from 1.0 to 1.7 with a mean of 1.48 +/- 0.08. The amount of drug ingested by the infants was 0.199 +/- 0.013 mg/kg/day which represented 22.1 +/- 1.9% of the maternal dose.


Leprosy Review | 1993

Borderline-tuberculoid relapse in lepromatous leprosy.

Girdhar Bk; Girdhar A; Chauhan Sl; Malaviya Gn; Husain S; Mukherjee A

We report details of 2 patients who had been treated for a long time by dapsone monotherapy and who had remained smear negative for over 10 years, but were found to have relapsed with borderline-tuberculoid (BT) leprosy.


Archive | 1989

Serological Survey of Leprosy Using a Monoclonal Antibody-Based Immunoassay and Phenolic Glycolipid ELISA

Sengupta U; Sudhir Sinha; S. A. Patil; Girdhar Bk; Ramu G

The present global estimate of leprosy patients is 11.5 million (21), one- fourth of whom live in India (6). The spread of infection can be arrested effectively by diagnosis and treatment of infectious subjects at an early (“preclinical”) stage (21). However, the available diagnostic tools are often inadequate for this purpose. Three of the Mycobacterium leprae-specific serological tests—the fluorescent leprosy-antibody absorption test (FLA- ABS), the phenolic glycolipid I-based enzyme-linked immunosorbent assay (PG-ELISA) and a monoclonal antibody—serum antibody competition test (SACT) have shown promising results when applied to the study of healthy contacts of leprosy patients (1,3,8,17,19). The present review is mainly attributed to the work done using SACT.


Leprosy Review | 2004

Nerve thickening in leprosy patients and risk of paralytic deformities: a field based study in Agra, India

Anil Kumar; Anita Girdhar; Girdhar Bk


International Journal of Leprosy and Other Mycobacterial Diseases | 1991

A clinical, immunological, and histological study of neuritic leprosy patients

Kaur G; Girdhar Bk; Girdhar A; Malaviya Gn; Mukherjee A; Sengupta U; Desikan Kv


Acta leprologica | 1995

Neuritic leprosy: further progression and significance.

Mishra B; Mukherjee A; Girdhar A; Husain S; Malaviya Gn; Girdhar Bk


Indian journal of leprosy | 2002

Pulsed corticosteroid therapy in patients with chronic recurrent ENL: a pilot study.

Anita Girdhar; Chakma Jk; Girdhar Bk

Collaboration


Dive into the Girdhar Bk's collaboration.

Top Co-Authors

Avatar

Anil Kumar

Indian Council of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Anita Girdhar

Indian Council of Medical Research

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Malaviya Gn

Indian Council of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Sengupta U

Indian Council of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Sudhir Sinha

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Utpal Sengupta

Indian Council of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Vinita Chaturvedi

Central Drug Research Institute

View shared research outputs
Top Co-Authors

Avatar

Beenu Joshi

Indian Council of Medical Research

View shared research outputs
Top Co-Authors

Avatar

Kiran Katoch

Indian Council of Medical Research

View shared research outputs
Researchain Logo
Decentralizing Knowledge